OTC Financial Network Announces Investment Opinion On SurgiLight Inc. OTC Financial Network Issues Research Report On SurgiLight Inc.
ORLANDO, Fla.-March 22, 2000- SurgiLight Inc. (OTCBB:SRGL)announced today that
OTC Financial Network, a division of National Financial Communications
Corporation (NFC) of Needham, Massachusetts, has issued an in-depth
analytic report on the Company. The report is available online, at
otcfn.com . The report is also available for reprint by
calling 781/444-6100, ext.11. Geoffrey J. Eiten, president of National Financial
Communications, commented, ``The market for laser applications in the
ophthalmology and dermatology industries is enormous, and SurgiLight, Inc. has
the innovative technology to assume a position of leadership.''
SurgiLight is a world leader in the development of new infrared technologies,
and a pioneer and inventor of scanning lasers and laser presbyopia reversal. The
Company continues to receive royalty income from international eye laser and
cosmetic centers. The presbyopia potential market is over $150 billion in US and
$1.4 trillion worldwide, according to SurgiLight's market analysis.
OTC Financial Network, a division of National Financial Communications Corp., is
a financial communications and investor relations firm specializing in the
representation of micro-cap companies.
Forward-looking statements in this release are made pursuant to the ``safe
harbor'' provisions of the Private Securities Litigation Reform Act of 1995.
Investors are cautioned that such forward-looking statements involve risks and
uncertainties, including without limitation, continued acceptance of the
Company's products, increased levels of competition for the Company, new
products and technological changes, the Company's dependence on third-party
suppliers, and other risks detailed from time to time in the Company's periodic
reports filed with the Securities and Exchange Commission.
OTC Financial Network, a division of National Financial Communications
Corporation, serves as a special advisor to the featured Company and has
received fees for services. This is not an offer to buy or sell securities.
Information or opinions in this report are presented solely for informative
purposes, and are not intended nor should they be construed as investment
advice. Contact: SurgiLight Inc. OTC Financial Network
J.T. Lin Geoffrey Eiten
407-482-4555 781-444-6100 x.13
Surgilight@aol.com geiten@otcfn.com
surgilight.com
-------------------------------------------------------------------------- |
